Advanced Manufacturing Investors & VC Firms in Asia-Pacific
27 firms in this list, with a median first check of $2.2M. 1 of them lead rounds. Generated from verified public data and updated continuously.
Shunwei Capital
Grand CaymanSeed–Growth
17 people
Acorn Pacific Ventures
San MateoSeed–Growth
8 people
Foundamental
Pre-Seed–Series A$500K – $5M
13 people
UOB Venture Management
SingaporeSeed–Growth$10M – $50M
8 people
Vertex Ventures China
SingaporePre-Seed–Late Stage
6 people
SBVA
SeoulSeed–Series B$1M – $2.5M
11 people
Impact Fund Denmark
Copenhagen KSeed–Late Stage$2.2M – $70.2M
11 people
Swedfund International AB
StockholmSeries A–Series B$3M – $10M
9 people
JAFCO Group
TokyoPre-Seed–Late Stage
8 people
Advantage Partners Inc.
TokyoGrowth–Late Stage
11 people
UMC Capital
TaipeiSeed–Late Stage
11 people
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Capital Group Private Markets
Growth$12M – $100M
4 people
Investible Climate Tech Fund
SydneyPre-Seed–Late Stage$330K
7 people
Hotung Investment Holdings Ltd.
TaipeiSeries A–Late Stage$300K – $1.5M
2 people
IDG Capital Vietnam
HanoiSeed–Late Stage$250K – $3M
2 people
Korea Investment Partners
SeoulSeries A–Late Stage$3M – $10M
1 person
Cathay Health
ParisSeed–Late Stage
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Metaplanet
TallinnSeed–Series A
2 people
Mizuho Capital
TokyoSeed–Late Stage
1 person
Advantech Capital
BeijingGrowth–Late Stage
1 person
Miller Capital Corporation
ScottsdaleGrowth
1 person
Raisewell Ventures
BerkeleyPre-Seed–Series B
1 person
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.